Log in
Log in
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. EC Healthcare
  6. News
  7. Summary
    2138   KYG3037S1021


Delayed Hong Kong Stock Exchange  -  03:08:03 2023-01-27 am EST
9.600 HKD   +0.42%
01/23EC Healthcare’s Sales Rise 8% in October-December 2022
01/20EC Healthcare Expects Third Quarter FY23 Sales Volume to Increase no less than 8% YoY
01/20Ec Healthcare Announces Sales Results for the Period from 1 October 2022 to 31 December 2022
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

EC Healthcare Acquires Multi-Disciplinary Healthcare Services Chain in Hong Kong

10/02/2022 | 10:17pm EST

HONG KONG, Oct 3, 2022 - (ACN Newswire) - - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group and the Seller enters into a sale and purchase agreement to acquire 60% of the issued share capital of Pioneer Evolution Limited (the "Target Company") for a total consideration of HK$36.4 million in cash.

The Target Company is a controlling holding company of a medical service provider which has a long-standing history in providing multi-disciplinary healthcare services in Hong Kong since 2002 and operates 9 medical centers under the business name of Sure-Care Medical and Health Network. Sure-Care Medical and Health Network has an extensive geographic coverage over Kowloon, New Territories and HK Island, including Mong Kok, Tai Po, Causeway Bay, Tsuen Wan and Jordan. Sure-Care Medical and Health Network also has a professional medical team of over 23 registered medical practitioners and covering 8 medical specialties and general medical services. According to the unaudited consolidated financial information, the profit after tax of the Target Company was approximately HK$5.9 million for the six months ended 30 June 2022 and HK$12.1 million for the year ended 31 December 2021. Upon completion of the acquisition, the financial results of the Target Company will be consolidated into the consolidated financial statements of the Group. The Seller guarantees to the Group with an accumulated net profit for the five years ending 31 December 2027 should be no less than HK$70 million.

The acquisition of the multi-disciplinary healthcare services is expected to deepen the Group's medical services layout and enable the Group to further increase its market share in the healthcare market. Upon the completion of the acquisition, the Group's full time registered doctor team will be expanded and the Group's medical services capability will be further strengthened in Hong Kong, particularly in New Territory East and expected to create cross referral to increase market share. Leveraging on the Group's operational excellence and efficiencies, the Group will empower Sure-Care Medical and Health Network to improve its asset value through corporatization.

Mr. Levin Lee, Executive Director and Chief Finance Officer of EC Healthcare, said, "EC Healthcare is always committed to building up an enclosed ecosystem to provide premium services to the client by leveraging multiple brands and disciplines. The acquisition is aligned with the Group's expansion strategy and will further consolidate the Group's leading market position in Hong Kong's healthcare market, maximizing overall shareholders' return. EC Healthcare will continue to be the leading market consolidator and develop its businesses through organic growth and mergers and acquisitions and strive to be the Asia leading healthcare services provider."

About EC Healthcare

EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.

The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, an advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.

*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021

For further information, please contact:

iPR Ogilvy Limited

Callis Lau / Lorraine Luk / Tim Tin / Sophia Wu

Tel: (852) 2136 6952 / 2169 0467 / 3920 7654 / 3920 7645

Fax: (852) 3170 6606

Email: ech@iprogilvy.com

Copyright 2022 ACN Newswire . All rights reserved.

© Japan Corporate News, source JCN Press Releases

All news about EC HEALTHCARE
01/23EC Healthcare’s Sales Rise 8% in October-December 2022
01/20EC Healthcare Expects Third Quarter FY23 Sales Volume to Increase no less than 8% YoY
01/20Ec Healthcare Announces Sales Results for the Period from 1 October 2022 to 31 December..
01/05EC Healthcare Grants 1.8 Million Share Options
2022Sharing Is (Not Always) Caring – Legal Pitfalls To Avoid When Engaging In Sharing..
2022EC Healthcare wins "Best in Healthcare Sector" at IR Magazine's Greater China Awards 20..
2022EC Healthcare's April-September Profit Falls on Higher Expenses
2022EC Healthcare Announces FY2022/23 Interim Results, Revenue Increased 31.1% YoY Mainly D..
2022EC Healthcare Announces Interim Dividend for the Six Months Ended 30 September 2022, Pa..
2022EC Healthcare Reports Earnings Results for the Half Year Ended September 30, 2022
More news
Sales 2023 3 793 M 484 M 484 M
Net income 2023 229 M 29,2 M 29,2 M
Net Debt 2023 - - -
P/E ratio 2023 50,0x
Yield 2023 1,26%
Capitalization 11 378 M 1 453 M 1 453 M
Capi. / Sales 2023 3,00x
Capi. / Sales 2024 2,40x
Nbr of Employees 2 557
Free-Float 38,7%
Duration : Period :
EC Healthcare Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EC HEALTHCARE
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 6
Last Close Price 9,60 HKD
Average target price 10,18 HKD
Spread / Average Target 6,04%
EPS Revisions
Managers and Directors
Lyn Wade Lu Co-Chief Executive Officer & Executive Director
Chi Fai Tang Chairman & Co-Chief Executive Officer
Heung Wing Lee Finance Director
Kun Shing Luk Non-Executive Director & Chief Information Officer
Tai Cheung Wong Chief Operating Officer
Sector and Competitors